Compare Natera Inc. Common Stock (NTRA) vs Restaurant Brands International Inc. Common Shares (QSR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Natera Inc. Common Stock vs Restaurant Brands International Inc. Common Shares — how do they compare? Natera Inc. Common Stock trades at $394 (market cap $57.03B), while Restaurant Brands International Inc. Common Shares trades at $73.03 (market cap $24.77B). The key difference: Natera Inc. Common Stock is far larger — about 2.3× Restaurant Brands International Inc. Common Shares's market cap, and Restaurant Brands International Inc. Common Shares pays a 3.65% dividend while Natera Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Natera Inc. Common Stock for 0 Days and Restaurant Brands International Inc. Common Shares for 6 Days on average.
| NTRA | QSR | |
|---|---|---|
Market Cap | $57.03B | $24.77B |
Volume | 1,131,157 | 3,180,422 |
Sector | Health | Consumer Cyclical |
52-Week High | $425.64 | $81.67 |
52-Week Low | $179.42 | $65.69 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $56.18B | $39.38B |
Dividend Yield | — | 3.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NTRA trades at $395.66, down 0.53% today but remains near recent highs. The stock shows mixed technical signals with neutral momentum indicators. Fundamentally, the company demonstrates strong revenue growth ($2.31B in 2025, projected $2.7B in 2026) but continues to operate at a net loss (-$208M in 2025). Recent positive developments include FDA Breakthrough Device designation for its multi-cancer detection assay and regulatory approval in Japan for Signatera.
NTRA presents a growth story with significant analyst support (89% buy ratings) but carries execution risks. The stock trades at premium valuations (P/S 20.48) while still unprofitable. Key catalysts include clinical trial progress and international expansion, though investors face risks from ongoing losses and competitive pressures in precision medicine.
QSR trades at $71.27, up 0.21% on the day, with a bearish technical signal driven by moving averages and oscillators. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.08. Revenue reached $9.43B in 2025, with net income of $776M, and is projected to grow to $9.7B in 2026. Analyst consensus is bullish with a price target of $84.80, supported by Burger King's turnaround momentum noted in recent news.
The outlook for QSR is positive due to strong earnings performance and analyst optimism, but near-term technical weakness and competitive pressures pose risks. Investment opportunity lies in execution of the Burger King revitalization and franchise strategy, while risks include market volatility and execution gaps in value offerings against rivals like McDonald's.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Natera Inc. Common Stock
Natera, Inc. develops and provides cell-free DNA-based genetic testing across women's health, oncology, organ health, and rare disease, with flagship products including Panorama for noninvasive prenatal screening and Signatera for cancer recurrence monitoring.
Read more on NTRA →About Restaurant Brands International Inc. Common Shares
Restaurant Brands International owns and franchises quick-service restaurant brands, including Burger King, Tim Hortons, Popeyes, and Firehouse Subs.
Read more on QSR →
